The recent consideration of CXCR1/R2 allosteric inhibitors for therapy of inflammatory lung diseases associated with fibrosis (26, 27) suggests that these inhibitors might be effective in treating BM fibrosis. This evidence concerns the gene CXCR1 and fibrosis.